PHP80 - HOW CLASSIFICATION OF CELL AND GENE THERAPIES AS DRUGS, DEVICES OR PROCEDURES COULD HAVE SIGNIFICANT IMPLICATIONS FOR THEIR PRICING AND REIMBURSEMENT AND COMMERCIAL SUCCESS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.974
https://www.valueinhealthjournal.com/article/S1098-3015(18)34276-1/fulltext
Title :
PHP80 - HOW CLASSIFICATION OF CELL AND GENE THERAPIES AS DRUGS, DEVICES OR PROCEDURES COULD HAVE SIGNIFICANT IMPLICATIONS FOR THEIR PRICING AND REIMBURSEMENT AND COMMERCIAL SUCCESS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34276-1&doi=10.1016/j.jval.2018.09.974
First page :
Section Title :
Open access? :
No
Section Order :
366